Connor, Clark & Lunn Investment Management (CC&L)’s Immunic IMUX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120,027
| Closed | -$131K | – | 1592 |
|
|
2025
Q1 | $131K | Sell |
120,027
-39,140
| -25% | -$42.7K | ﹤0.01% | 1346 |
|
|
2024
Q4 | $159K | Buy |
159,167
+56,910
| +56% | +$56.9K | ﹤0.01% | 1345 |
|
|
2024
Q3 | $169K | Buy |
102,257
+42,383
| +71% | +$69.9K | ﹤0.01% | 1338 |
|
|
2024
Q2 | $66.5K | Buy |
59,874
+330
| +0.6% | +$366 | ﹤0.01% | 1325 |
|
|
2024
Q1 | $78.6K | Buy |
+59,544
| New | +$78.6K | ﹤0.01% | 1475 |
|
|
2023
Q4 | – | Sell |
-24,773
| Closed | -$36.4K | – | 1468 |
|
|
2023
Q3 | $36.4K | Sell |
24,773
-82,739
| -77% | -$122K | ﹤0.01% | 1324 |
|
|
2023
Q2 | $270K | Buy |
107,512
+20,605
| +24% | +$51.7K | ﹤0.01% | 1129 |
|
|
2023
Q1 | $129K | Buy |
+86,907
| New | +$129K | ﹤0.01% | 1135 |
|